Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Oct 14, 2008New SYNTAX Score shows similar safety and efficacy outcomes for two thirds of study's patients
Boston Scientific Corporation (NYSE: BSX) today announced 12-month left main and three-vessel disease subset data from its landmark...
-
Oct 14, 2008Company moves up Q3 earnings release date
Boston Scientific Corporation (NYSE: BSX) today provided the following comments reinforcing the strength of its balance sheet: The volatility of...
-
Oct 14, 2008TAXUS® Atom™ in more than 500 accounts Company opening new PROMUS™ accounts
Boston Scientific Corporation (NYSE: BSX) today announced estimated U.S. market shares for September for its two drug-eluting stents (DES), based...
-
Oct 13, 2008Joint efforts will focus on intravascular ultrasound (IVUS)
GE Healthcare (NYSE: GE) and intravascular ultrasound (IVUS) market leader Boston Scientific Corporation (NYSE: BSX) today...
-
Oct 13, 2008
Thursday and Friday of last week saw continued heavy trading in Boston Scientific's (NYSE: BSX) stock. As anticipated in the Company's October 9th...
-
Oct 12, 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of nearly 7,500 patients from its TAXUS ARRIVE 1...
-
Oct 12, 2008New coronary stent features thin struts designed for more uniform drug delivery
Boston Scientific Corporation (NYSE: BSX) today announced comprehensive data from the TAXUS ATLAS clinical program, a series of...
-
Oct 10, 2008
Boston Scientific Corporation (NYSE: BSX) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its...
-
Oct 10, 2008
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Cardiovascular...
-
Oct 9, 2008
Yesterday saw heavy trading in Boston Scientific's (NYSE: BSX) stock, with approximately 38 million shares traded. This trading included involuntary...
-
Oct 8, 2008
Boston Scientific (NYSE: BSX) announced today it expects to record the following adjustments to its third quarter results, which it plans to report...
-
Oct 8, 2008PERSEUS clinical program to evaluate TAXUS® Element™ Platinum Chromium Stent
Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in the PERSEUS trial, designed to evaluate the Company's...
-
Oct 1, 2008
Boston Scientific Corporation (NYSE: BSX) announced today that the United States District Court in Delaware has entered judgment against the Company...
-
Sep 25, 2008Company also announces FDA approval of TAXUS® Express2™ Stent System for treatment of in-stent restenosis
Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market...
-
Sep 19, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the UBS Global Life Sciences Conference, which is being held September 22...
-
Sep 15, 2008
Boston Scientific Corporation (NYSE: BSX) announced today a decision by the United States District Court in Delaware. The case involves a patent...
-
Sep 9, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America 38th Annual Investment Conference which is being held...
-
Sep 2, 2008
Boston Scientific Corporation (NYSE: BSX) today announced positive one-year results from the European and Intercontinental...
-
Sep 1, 2008
Boston Scientific Corporation (NYSE: BSX) today announced one-year data from its landmark SYNTAX trial comparing percutaneous...
-
Aug 29, 2008Boston Scientific obligation reduced from $250 to $19 million
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. District Court of Marshall, Texas found two patents of Medtronic, Inc....
-
Aug 26, 2008Company to present data from landmark SYNTAX clinical trial
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the European...
-
Jul 21, 2008
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the second quarter ended June 30, 2008, as well as guidance for net...
-
Jul 2, 2008Boston Scientific only company to offer choice of two distinct drugs on separate drug-eluting stent platforms
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved the PROMUS™...
-
Jun 26, 2008
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2008...
-
Jun 23, 2008
Boston Scientific Corporation (NYSE: BSX) today welcomed progress on a number of pieces of legislation that will help service veterans and the...
-
Jun 19, 2008Transactions further Company's plans to focus on core businesses and increase shareholder value
Boston Scientific Corporation - today announced that it has signed a definitive agreement to sell its investments in a portfolio of companies,...
-
Jun 9, 2008
Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by Fitch Ratings that it has revised its Rating Outlook on the Company, to...
-
Jun 5, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in Goldman Sachs' Annual Healthcare Conference, which is being held June 9-12...
-
Jun 3, 2008Company announces management changes and further organizational consolidation
Boston Scientific Corporation (NYSE: BSX) announced today that President and Chief Executive Officer Jim Tobin will be extending his tenure at the...
-
May 29, 2008Environmentally focused improvements are hallmark of renovations to Endosurgery headquarters
Boston Scientific Corporation (NYSE: BSX) today announced it has received Leadership in Energy and Environmental Design (LEED) certification from...
-
May 28, 2008
Boston Scientific Corporation (NYSE: BSX) and CryoCor, Inc. (NASDAQ: CRYO) today announced that Boston Scientific has completed its...
-
May 28, 2008
Boston Scientific Corporation (NYSE: BSX) today announced that a U.S. District Court jury in Marshall, Texas has reached a verdict in a patent...
-
May 20, 2008Positive results presented at Digestive Disease Week® 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an international, multi-center patient registry documenting...
-
May 19, 2008New size allows for treatment of smaller-diameter diseased saphenous vein grafts
Boston Scientific Corporation (NYSE: BSX) today announced the launch of its FilterWire EZ™ Embolic Protection System in a new 2.25 - 3.5 mm size,...
-
May 16, 2008ACUITY® Spiral lead has smallest left ventricular lead tip profile in the industry
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval of its ACUITY® Spiral left ventricular...
-
May 16, 2008Results of international, multi-center registry presented at conference
Boston Scientific Corporation (NYSE: BSX) today announced that results from an international, multi-center patient registry documenting the safety...
-
May 15, 2008ALTITUDE clinical science initiative will provide insights to ICD and CRT-D device therapy
Boston Scientific Corporation (NYSE: BSX) today announced a new clinical science initiative, ALTITUDE, which will analyze data(1) from the...
-
May 13, 2008COGNIS™ CRT-D and TELIGEN™ ICD represent entirely new platforms
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval of its COGNIS™ cardiac...
-
May 13, 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of nearly 7,500 patients from its TAXUS...
-
May 13, 2008
Boston Scientific Corporation (NYSE: BSX) today welcomed two-year results from the SPIRIT III clinical trial, which continue to...
-
May 13, 2008Company supports efforts of International Diabetes Federation to promote worldwide diabetes care and prevention
Boston Scientific Corporation (NYSE: BSX) and the International Diabetes Federation (IDF) today announced that Boston...
-
May 8, 2008
Boston Scientific Corporation (NYSE: BSX) announced today that the Canadian Federal Court has issued judgment in a lawsuit in which Johnson & Johnson...
-
May 8, 2008
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval of its ALTRUA™ family of pacemakers....
-
May 7, 2008Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval and market launch of its ALTRUA™ family of pacemakers. ALTRUA is Boston...
-
May 5, 2008
Boston Scientific Corporation (NYSE: BSX) announced today that a World Intellectual Property Organization (WIPO) arbitration panel has issued its...
-
Apr 30, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Deutsche Bank Health Care Conference, which is being held May 5-7 in...
-
Apr 24, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Morgan Stanley Global Healthcare Unplugged Conference, which is being...
-
Apr 24, 2008
Boston Scientific Corporation (NYSE: BSX) today announced completion of enrollment in the Multicenter Automatic Defibrillator Implantation Trial...
-
Apr 23, 2008
Boston Scientific Corporation (NYSE: BSX) today announced that it has been named U.S. Healthcare Supplier of the Year in the GHXcellence Awards...
-
Apr 21, 2008
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the first quarter ended March 31, 2008, as well as guidance for...